Abstract Recombinant Saccharomyces cerevisiae (yeast) represents a unique and attractive vehicle for delivering antigens in cancer or infectious disease vaccine immunotherapy protocols, as it has
Day: January 27, 2022
Rabies virus Recombinants
Abstract Recombinant, replication-competent rabies virus (RV) vaccine strain-based vectors expressing HIV type I (HIV-1) envelope glycoprotein (gp160) were developed from both a laboratory-adapted ( CXCR4-tropic)
Other Organism Recombinants
Abstract The discoveries of the double-stranded structure of DNA and the development of recombinant DNA technology sparked a revolution in industrial microbiology. Traditional industrial microbiology